The adequacy of pain management for individuals with cancer who receive outpatient chemotherapy is unclear. The primary objective of this study was to assess pain prevalence and intensity in such patients. The secondary objectives included assessment of pain management with the pain management index (PMI) and exploration of predictors of inadequate pain management.
Cancer patients who received outpatient chemotherapy were enrolled. Patients were required to complete questionnaires covering demographic data and including the Brief Pain Inventory and the Distress Thermometer and Impact Thermometer. The PMI score was determined twice with an interval of at least 3 weeks.
Of the 740 patients enrolled in the study, 524 individuals (70.8%) completed all questionnaires. Totals of 282 patients (53.8%) and 264 patients (50.4%) reported pain at baseline and follow-up, respectively, with ∼14% of patients having moderate or severe pain at each assessment. Totals of 365 patients (69.7%) at baseline and 320 patients (61.1%) at follow-up reported pain or were prescribed analgesics, with the rate of inadequate pain management for these patients being 39.7 and 51.6%, respectively. Multivariable analysis for 418 patients (79.8%) who had pain or required analgesics at baseline or follow-up (or both) revealed that the most significant predictor of inadequate pain management was depressive state.
Pain in cancer patients receiving outpatient chemotherapy is prevalent and at risk for undertreatment. Pain management should be assessed on a regular basis and is likely to be improved by screening for depression.
Fisch MJ, Lee JW, Weiss M, Wagner LI, Chang VT, Cella D, Manola JB, Minasian LM, McCaskill-Stevens W, Mendoza TR, Cleeland CS (2012) Prospective, observational study of pain and analgesic prescribing in medical oncology outpatients with breast, colorectal, lung, or prostate cancer. J Clin Oncol 30:1980–1988 CrossRefPubMedPubMedCentral
von Moos R, Body JJ, Egerdie B, Stopeck A, Brown J, Fallowfield L, Patrick DL, Cleeland C, Damyanov D, Palazzo FS, Marx G, Zhou Y, Braun A, Balakumaran A, Qian Y (2016) Pain and analgesic use associated with skeletal-related events in patients with advanced cancer and bone metastases. Support Care Cancer 24:1327–1337 CrossRef
Dollinger M (1996) Guidelines for hospitalization for chemotherapy. Oncologist 1:107–111 PubMed
Nelson CJ, Cho C, Berk AR, Holland J, Roth AJ (2010) Are gold standard depression measures appropriate for use in geriatric cancer patients? A systematic evaluation of self-report depression instruments used with geriatric, cancer, and geriatric cancer samples. J Clin Oncol 28:348–356 CrossRefPubMed
Kwon JH, Oh SY, Chisholm G, Lee JA, Lee JJ, Park KW, Nam SH, Song HH, Lee K, Zang DY, Kim HY, Choi DR, Kim HJ, Kim JH, Jung JY, Jang G, Kim HS, Won JY, Bruera E (2013) Predictors of high score patient-reported barriers to controlling cancer pain: a preliminary report. Support Care Cancer 21:1175–1183 CrossRefPubMed
Tateno Y, Ishikawa S (2012) Clinical pathways can improve the quality of pain management in home palliative care in remote locations: retrospective study on Kozu Island. Japan Rural Remote Health 12:1992 PubMed
Uki J, Mendoza T, Cleeland CS, Nakamura Y, Takeda F (1998) A brief cancer pain assessment tool in Japanese: the utility of the Japanese brief pain inventory—BPI-J. J Pain Symptom Management 16:364–373 CrossRef
Akizuki N, Yamawaki S, Akechi T, Nakano T, Uchitomi Y (2005) Development of an impact thermometer for use in combination with the distress thermometer as a brief screening tool for adjustment disorders and/or major depression in cancer patients. J Pain Symptom Management 29:91–99 CrossRef
- Longitudinal assessment of pain management with the pain management index in cancer outpatients receiving chemotherapy
- Springer Berlin Heidelberg
Neu im Fachgebiet Onkologie
Mail Icon II